hrough an RNAi synthetic lethal screen we have identified the protein SUMOylation pathway to be required for the viability of Ras mutant cancer cells.PURPOSEIn this project we aim to address the following questions: 1) the mechanism by which the inhibition of SUMOylation pathway is synthetically lethal with Ras mutation;2) which cellular proteins are differentially SUMOylated in Ras mutant cells;and 3) How the changes in SUMOylation status of these proteins affect their function in the context of Ras mutant tumors.SIGNIFICANT MATERIALS AND METHODS1) shRNAs that target the SUMO E1 and E2 ligases and SUMO pathway proteins;2) Stable cell lines expressing SUMO proteins and ligases; 3) mass-spectrometry protocol for identifying SUMOylated proteins in cell lysates.FY2012 ACCOMPLISHMENTContinuing our effort from FY2011, we have identified a number of candidate proteins that are differentially SUMOylated between Ras WT and mutant cells. We are currently studying the functions of these SUMOylated proteins in KRAS mutant cells. We are also investigating how SUMOylation affects the activity of these proteins.
| Zhang, Haibo; Luo, Ji (2016) SUMO wrestling with Ras. Small GTPases 7:39-46 |
| Ma, Chi; Kesarwala, Aparna H; Eggert, Tobias et al. (2016) NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531:253-7 |
| Yu, Bing; Swatkoski, Stephen; Holly, Alesia et al. (2015) Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci U S A 112:E1724-33 |
| Kessler, Jessica D; Kahle, Kristopher T; Sun, Tingting et al. (2012) A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335:348-53 |
| Weng, Meng-Tzu; Lee, Jih-Hsiang; Wei, Shu-Chen et al. (2012) Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A 109:E3659-67 |
